Blackhawk Capital Partners’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-37,776
Closed -$2.14M 74
2022
Q1
$2.14M Sell
37,776
-2,339
-6% -$125K 1.45% 20
2021
Q4
$2.07M Buy
40,115
+8,566
+27% +$420K 1.25% 30
2021
Q3
$1.56M Buy
31,549
+9,533
+43% +$517K 0.99% 33
2021
Q2
$1.34M Buy
22,016
+802
+4% +$46.9K 0.91% 43
2021
Q1
$1.14M Buy
21,214
+1,707
+9% +$94.2K 0.86% 41
2020
Q4
$916K Buy
19,507
+1,986
+11% +$103K 0.78% 45
2020
Q3
$914K Sell
17,521
-5,609
-24% -$288K 0.83% 41
2020
Q2
$1.11M Sell
23,130
-1,419
-6% -$73.2K 1.32% 27
2020
Q1
$1.24M Sell
24,549
-3,590
-13% -$186K 1.11% 35
2019
Q4
$1.33M Hold
28,139
1.32% 30
2019
Q3
$1.33M Buy
+28,139
New +$1.28M 1.24% 32
2018
Q2
Sell
-6,865
Closed -$430K 320
2018
Q1
$430K Sell
6,865
-606
-8% -$41.6K 0.37% 64
2017
Q4
$458K Buy
+7,471
New +$462K 0.4% 64

Other funds holding CAH

Blackhawk Capital Partners's CAH Position: Q2 2022 in Review

Blackhawk Capital Partners sold out of Cardinal Health (CAH) in Q2 2022, closing a stake of 37,776 shares — an estimated $2.14M sold.

Blackhawk Capital Partners first reported a position in CAH in Q4 2017 and held it in 13 quarters. The position peaked at $2.14M in Q1 2022. 793 funds tracked by Wall St. Rank hold CAH as of Q2 2022.

  • Blackhawk Capital Partners reported no remaining Cardinal Health position as of Q2 2022 after selling out during the quarter.
  • Blackhawk Capital Partners sold 37,776 Cardinal Health shares in Q2 2022, an estimated $2.14M.
  • Blackhawk Capital Partners first reported a position in Cardinal Health in Q4 2017 and held it in 13 quarters.
  • Blackhawk Capital Partners's Cardinal Health position peaked at $2.14M in Q1 2022.
  • 793 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2022.

Based on Blackhawk Capital Partners's 13F filing for Q2 2022, filed 8 Aug 2022.